Zhong Yuan Bio-Technology Holdings Limited (ZHYBF) Investment Research Dashboard
About Zhong Yuan Bio-Technology Holdings Limited (ZHYBF) stock analysis
Get live ZHYBF stock price $2.02, comprehensive Zhong Yuan Bio-Technology Holdings Limited stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time ZHYBF stock data and investment insights.
Loading chart data...
Zhong Yuan Bio-Technology Holdings Limited (ZHYBF) Overview
Zhong Yuan Bio-Technology Holdings Limited (ZHYBF) is a publicly traded company in the Healthcare sector , specifically within the Medical - Distribution industry . As of the latest trading session, ZHYBF trades at $2.02 with a market capitalization of 35.75M . Over the past 52 weeks, ZHYBF has traded between $2.00 and $2.02 , with the current price positioned at approximately 100% of this rang...
Key Takeaways
- Operates in the Healthcare sector (Medical - Distribution)
- Market cap: 35.75M
- Current price: $2.02
- 52-week range: $2.00 - $2.02
- P/E ratio: 101.00
Investment Score
A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Zhong Yuan Bio-Technology Holdings Limited engages in the sale of plant-derived nervonic acid dietary supplements in China. It operates through four segments: Sales of Dietary Supplements; Research and Development Services; Royalties; and Event Organ...
Company Information
- CEO
- Ting Ting Chang
- Sector
- Healthcare
- Industry
- Medical - Distribution
- Employees
- 23
Contact Information
- Website
- https://www.zhybiotech.com
- Address
- Tesbury Centre
- Country
- HK
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Growth-oriented company with premium valuation (P/E: 101.0)
✓ Higher growth potential with elevated volatility (Beta: 3.96)
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Zhong Yuan Bio-Technology Holdings Limited shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Zhong Yuan Bio-Technology Holdings Limited
- ⚠Investors should consider how Zhong Yuan Bio-Technology Holdings Limited fits within their overall portfolio allocation
- ⚠Premium valuation (P/E: 101.0) requires strong growth to justify
Market Cap
35.75M
P/E Ratio (TTM)
101.00
Beta
3.96
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare ZHYBF with peer companies:
- Price
- $0.13+0.00% (1D)
- Market cap
- 4.60M
- Price
- $1.24-5.34% (1D)
- Market cap
- 15.74M
- Price
- $0.06-20.78% (1D)
- Market cap
- 8.30M
- Price
- $0.66+0.00% (1D)
- Market cap
- 13.45M
- Price
- $0.67+5.05% (1D)
- Market cap
- 20.36M
- Price
- $2.81+0.36% (1D)
- Market cap
- 21.82M
- Price
- $0.03-0.34% (1D)
- Market cap
- 2.93M
- Price
- $0.26+0.00% (1D)
- Market cap
- 14.21M
- Price
- $0.37+0.00% (1D)
- Market cap
- 14.80M
- Price
- $4.20+0.00% (1D)
- Market cap
- 40.29M
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.
Healthcare (1D)
77/100 ⭐⭐⭐⭐⭐
- Overall
- +0.3%
- NYSE
- +0.7%
- NASDAQ
- -0.2%
| Sector | 1D | 1W | 1M | P/E | Score |
|---|---|---|---|---|---|
| Financial Services | +0.3% | +1.5% | +2.2% | 19.1 | 82/100⭐⭐⭐⭐⭐ |
| Healthcare | +0.3% | +2.7% | +1.5% | 23.5 | 77/100⭐⭐⭐⭐⭐ |
| Real Estate | +1.8% | +4.6% | +0.7% | 29.8 | 72/100⭐⭐⭐⭐⭐ |
| Communication Services | +0.7% | -2.1% | +2.2% | 21.8 | 70/100⭐⭐⭐⭐⭐ |
| Basic Materials | +0.9% | +2.0% | -0.3% | 25.0 | 60/100⭐⭐⭐⭐ |
| Consumer Defensive | +0.8% | +1.0% | -0.2% | 28.7 | 55/100⭐⭐⭐⭐ |
| Utilities | -0.7% | +2.5% | -1.9% | 25.2 | 49/100⭐⭐⭐ |
| Energy | -0.2% | -0.4% | -2.4% | 19.6 | 42/100⭐⭐⭐ |
| Consumer Cyclical | +0.3% | -1.6% | -4.0% | 43.3 | 17/100⭐ |
| Industrials | -0.5% | -0.1% | -8.9% | 30.4 | 15/100⭐ |
| Technology | -1.6% | -0.8% | -5.3% | 42.2 | 12/100⭐ |
Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-07-27.